Nabiqasim Industries (pvt) Ltd
Clinical trials sponsored by Nabiqasim Industries (pvt) Ltd, explained in plain language.
Upcoming readouts
Trials from this sponsor expected to report results within the next 12 months.
- FDA-Approved MASH drug gets Real-World test in pakistan Results expected Oct 2026 (estimated)
- New registry tracks Real-World use of kidney anemia drug Results expected Jan 2027 (estimated)
- New registry aims to uncover hidden patterns of erectile dysfunction in diabetic men Results expected Feb 2027 (estimated)
-
One pill to rule them all? triple diabetes combo under study
Disease control Recruiting nowThis study tests a single pill containing three diabetes drugs (empagliflozin, linagliptin, and metformin) in 800 adults with type 2 diabetes. The goal is to see if the triple combination improves blood sugar control, weight, quality of life, and treatment satisfaction compared t…
Phase 4 • Sponsor: Nabiqasim Industries (Pvt) Ltd • Aim: Disease control
Last updated Jun 27, 2026 12:09 UTC
-
FDA-Approved MASH drug gets Real-World test in pakistan
Disease control Recruiting nowThis study tests resmiterom, the first FDA-approved drug for MASH (a type of fatty liver disease), in 165 Pakistani patients. Researchers will check how safe it is and whether it improves liver health using non-invasive scans. The goal is to see if the drug works well in this spe…
Phase 4 • Sponsor: Nabiqasim Industries (Pvt) Ltd • Aim: Disease control
Last updated Jun 27, 2026 08:01 UTC